Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting central nervous system disorders. Its structural features support binding to neurotransmitter receptors, making it valuable in developing treatments for depression, anxiety, and neuropathic pain. The compound's fluorinated benzoyl group enhances blood-brain barrier penetration, improving efficacy in CNS-targeted drugs. It is also explored in structure-activity relationship (SAR) studies to optimize potency and selectivity of novel therapeutics.